Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Plasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis — Stella

Home/Nasopharyngeal Carcinoma/

View on ClinicalTrials.gov

Recruiting

Back to Nasopharyngeal Carcinoma trials

Trial locations(5 sites)

China

Nanfang hospital, Southern medical university, Guangzhou, Guangdong

Fujian Provinical Hospital, Fuzhou

Huizhou Central People's Hospital, Huizhou

Jieyang People's Hospital, Jieyang

Meizhou People's Hospital, Meizhou Academy of Medical Sciences Meizhou, Meizhou

Key details

Sponsor

Nanfang Hospital, Southern Medical University

Enrollment target

~300 participants

Started

February 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated March 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.